ACAD logo

ACADIA Pharmaceuticals (ACAD)

Profile

Full Name

ACADIA Pharmaceuticals Inc.

Ticker Symbol

ACAD

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 27, 2004

Indexes

Not included

Website

http://www.acadia.com

Employees

653

Key Details

Price

$14.73(+1.10%)

Market cap

$2.46B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$957.80M(+31.85% YoY)

Annual EPS

$1.36(+467.57% YoY)

PE ratio

10.83

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$14.73
ACAD price is $14.73

30-Day Relative Volume

0.70
ACAD 30-day relative volume is 0.70

Price Performance

Price Most recent change

+1.1%
ACAD price was up +1.1% on Apr 17, 2025

Price YTD change

-19.73%
ACAD price is down -19.73% since January 1st

Price 1-year change

-14.31%
ACAD price is down -14.31% year-on-year

Price 3-year change

-37.24%
ACAD price is down -37.24% over the past 3 years

Price Range

Price All-time high

$58.72
ACAD price is currently -74.91% below its historical high of $58.72

Price 3-year low

$12.24
ACAD price is currently +20.34% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.46B
ACAD market capitalization is $2.46 billion

Market cap 3-year change

-35.14%
ACAD market capitalization is down -35.14% over the past 3 years

Market cap All-time high

$9.03B
ACAD market capitalization is currently -72.79% below its historical high of $9.03 billion

Market cap sector rank

84.77%
ACAD market capitalization is higher than 84.77% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.11%
ACAD shares outstanding is up +1.11% year-on-year

Shares Outstanding 3-Year Change

+3.35%
ACAD shares outstanding is up +3.35% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.85
ACAD beta is 0.85

200-day SMA

$16.85
ACAD price is currently -12.60% below its 200-day simple moving average

50-day SMA

$17.38
ACAD price is currently -15.25% below its 50-day simple moving average

RSI

38.06
ACAD 14-day relative strength index is 38.06

Volume

0.70
ACAD 30-day relative volume is 0.70

ATR

$0.73
ACAD average true range is $0.73

10-day Historical Volatility

63.85%
ACAD 10-day historical volatility is 63.85%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$957.80M
ACAD annual revenue is $957.80 million

Revenue Analysts estimate

$1.06B
ACAD annual revenue is currently -9.80% lower than the consensus analysts' forecast

Revenue 1-year change

+31.85%
ACAD annual revenue is up +31.85% year-on-year

Revenue Sector rank

80.16%
ACAD annual revenue is higher than 80.16% of companies in Healthcare sector

EPS

EPS

$1.36
ACAD annual earnings per share is $1.36

EPS Analysts estimate

$0.59
ACAD annual earnings per share is currently +129.73% higher than the consensus analysts' forecast

EPS 1-year change

+467.57%
ACAD annual earnings per share is up +467.57% year-on-year

EPS Sector rank

90.64%
ACAD annual earnings per share is higher than 90.64% of companies in Healthcare sector

Profit

Gross profit

$875.96M
ACAD annual gross profit is $875.96 million

Gross margin

91.46%
ACAD annual gross profit margin is 91.46%

Operating profit

$84.28M
ACAD annual operating income is $84.28 million

Operating margin

8.80%
ACAD annual operating profit margin is 8.80%

Net income

$226.45M
ACAD annual net profit is $226.45 million

Net margin

23.64%
ACAD annual net profit margin is 23.64%

Expenses

Total expenses

$873.52M
ACAD annual total expenses is $873.52 million

Operating expenses

$791.68M
ACAD annual total operating expenses is $791.68 million

Cost of goods sold

$81.84M
ACAD annual cost of goods sold is $81.84 million

Selling, general & administrative expenses

$488.43M
ACAD annual SGA is $488.43 million

Depreciation and amortization

$15.88M
ACAD annual depreciation & amortization is $15.88 million

Interest expense

-
ACAD annual interest expense value is unknown

Income tax

$31.62M
ACAD annual income tax is $31.62 million

EBIT & EBITDA

EBIT

$84.28M
ACAD annual earnings before interest & taxes is $84.28 million

EBITDA

$100.16M
ACAD annual EBITDA is $100.16 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.19B
ACAD annual total assets is $1.19 billion

Non current assets

$249.44M
ACAD annual long term assets is $249.44 million

Current assets

$938.32M
ACAD annual total current assets is $938.32 million

Cash and cash equivalents

$319.59M
ACAD annual cash & cash equivalents is $319.59 million

Accounts receivable

$98.74M
ACAD annual accounts receivable is $98.74 million

Inventory

$21.95M
ACAD annual inventory is $21.95 million

Liabilities

Total liabilities

$454.96M
ACAD annual total liabilities is $454.96 million

Long term liabilities

$60.09M
ACAD annual total long term liabilities is $60.09 million

Current liabilities

$394.87M
ACAD annual total current liabilities is $394.87 million

Accounts payable

$16.19M
ACAD annual accounts payable is $16.19 million

Debt

Total debt

$51.99M
ACAD annual total debt is $51.99 million

Total debt 1-year change

-9.11%
ACAD annual total debt is down -9.11% year-on-year

Long term debt

$42.04M
ACAD annual long term debt is $42.04 million

Short term debt

$9.96M
ACAD annual short term debt is $9.96 million

Equity & Capital

Shareholders equity

$732.79M
ACAD annual stockholders equity is $732.79 million

Book value

$732.79M
ACAD annual book value is $732.79 million

Retained earnings

-$2.20B
ACAD annual retained earnings is -$2.20 billion

Working capital

$543.45M
ACAD annual working capital is $543.45 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$157.72M
ACAD annual cash flow from operations is $157.72 million

Cash from operations 1-year change

+844.31%
ACAD annual cash flow from operations is up +844.31% year-on-year

Cash from investing

-$30.54M
ACAD annual cash flow from investing activities is -$30.54 million

Cash from investing 1-year change

-195.44%
ACAD annual cash flow from investing activities is down -195.44% year-on-year

Cash from financing

$6.84M
ACAD annual cash flow from financing activities is $6.84 million

Cash from financing 1-year change

-72.76%
ACAD annual cash flow from financing activities is down -72.76% year-on-year

CAPEX

CAPEX

$523.00K
ACAD annual capital expenditures is $523.00 thousand

CAPEX 1-year change

-98.69%
ACAD annual capital expenditures is down -98.69% year-on-year

Free Cash Flow

Free cash flow

$157.20M
ACAD annual free cash flow is $157.20 million

Free cash flow 1-year change

+773.27%
ACAD annual free cash flow is up +773.27% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

91.46%
ACAD annual gross profit margin is 91.46%

Operating margin

8.80%
ACAD annual operating profit margin is 8.80%

Net margin

23.64%
ACAD annual net profit margin is 23.64%

ROA & ROE

ROA

23.39%
ACAD annual return on assets is 23.39%

ROE

38.89%
ACAD annual return on equity is 38.89%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

10.83
ACAD price to earnings ratio is 10.83

PE ratio Sector rank

16.18%
ACAD price to earnings ratio is higher than 16.18% of companies in Healthcare sector

PB Ratio

PB ratio

3.35
ACAD price to book ratio is 3.35

PB ratio Sector rank

74.61%
ACAD price to book ratio is higher than 74.61% of companies in Healthcare sector

PS Ratio

PS ratio

2.57
ACAD price to sales ratio is 2.57

PS ratio Sector rank

47.88%
ACAD price to sales ratio is higher than 47.88% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.19B
ACAD enterprise value is $2.19 billion

Enterprise value Sector rank

82.98%
ACAD enterprise value is higher than 82.98% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

21.86
ACAD EV/EBITDA is 21.86

EV/EBITDA Sector rank

92.6%
ACAD EV/EBITDA is higher than 92.6% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.38
ACAD annual current ratio is 2.38

Quick ratio

2.32
ACAD annual quick ratio is 2.32

Leverage

Debt to equity

0.00
ACAD annual debt to equity ratio is 0.00

Interest coverage ratio

-
ACAD annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

4
ACAD piotroski f-score is 4

Altman Z-Score

2.23
ACAD altman z-score is 2.23

Analyst ratings

Recent major analysts updates

Apr 8, 25 Needham
Buy
Feb 27, 25 Needham
Buy
Feb 27, 25 HC Wainwright & Co.
Buy
Feb 27, 25 Cantor Fitzgerald
Overweight
Feb 11, 25 Deutsche Bank
Hold
Jan 3, 25 Guggenheim
Neutral
Nov 7, 24 Needham
Buy
Nov 7, 24 HC Wainwright & Co.
Buy
Aug 8, 24 UBS
Buy
Aug 8, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

VCYT logo
Veracyte (VCYT)
MLTX logo
MoonLake Immunotherapeutics (MLTX)
ALVO logo
Alvotech (ALVO)
XRAY logo
DENTSPLY SIRONA (XRAY)
HCM logo
HUTCHMED (China) Limited (HCM)
IMVT logo
Immunovant (IMVT)
LFST logo
LifeStance Health (LFST)
Concentra Group Holdings Parent (CON)
NVST logo
Envista Holdings (NVST)
  • What is the ticker symbol for ACADIA Pharmaceuticals?
  • Does ACADIA Pharmaceuticals pay dividends?
  • What sector is ACADIA Pharmaceuticals in?
  • What industry is ACADIA Pharmaceuticals in?
  • What country is ACADIA Pharmaceuticals based in?
  • When did ACADIA Pharmaceuticals go public?
  • Is ACADIA Pharmaceuticals in the S&P 500?
  • Is ACADIA Pharmaceuticals in the NASDAQ 100?
  • Is ACADIA Pharmaceuticals in the Dow Jones?
  • When was ACADIA Pharmaceuticals's last earnings report?
  • When does ACADIA Pharmaceuticals report earnings?
  • Should I buy ACADIA Pharmaceuticals stock now?

What is the ticker symbol for ACADIA Pharmaceuticals?

The ticker symbol for ACADIA Pharmaceuticals is NASDAQ:ACAD

Does ACADIA Pharmaceuticals pay dividends?

No, ACADIA Pharmaceuticals does not pay dividends

What sector is ACADIA Pharmaceuticals in?

ACADIA Pharmaceuticals is in the Healthcare sector

What industry is ACADIA Pharmaceuticals in?

ACADIA Pharmaceuticals is in the Biotechnology industry

What country is ACADIA Pharmaceuticals based in?

ACADIA Pharmaceuticals is headquartered in United States

When did ACADIA Pharmaceuticals go public?

ACADIA Pharmaceuticals's initial public offering (IPO) was on May 27, 2004

Is ACADIA Pharmaceuticals in the S&P 500?

No, ACADIA Pharmaceuticals is not included in the S&P 500 index

Is ACADIA Pharmaceuticals in the NASDAQ 100?

No, ACADIA Pharmaceuticals is not included in the NASDAQ 100 index

Is ACADIA Pharmaceuticals in the Dow Jones?

No, ACADIA Pharmaceuticals is not included in the Dow Jones index

When was ACADIA Pharmaceuticals's last earnings report?

ACADIA Pharmaceuticals's most recent earnings report was on Feb 26, 2025

When does ACADIA Pharmaceuticals report earnings?

The next expected earnings date for ACADIA Pharmaceuticals is May 8, 2025

Should I buy ACADIA Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page